Search results
Results From The WOW.Com Content Network
The company posted quarterly revenue of $1.61 billion, beating analysts' average estimate of $1.57 billion. "In the United States, the Dobbs decision has driven an increase in demand from patients ...
Organon (OGN) delivered earnings and revenue surprises of 17.86% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
For premium support please call: 800-290-4726 more ways to reach us
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. [4] Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
Stocks lost ground in the early going after the Labor Department reported Friday that its producer price index, which measures inflation before it hits consumers, rose 0.8% last month from July 2022.
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
On January 1, 2020, CRSP spun off from Chicago Booth and became Center for Research in Security Prices, LLC. CRSP, LLC is an affiliate of the University of Chicago Booth School of Business. CRSP's flagship databases include: Common stocks on the NYSE from 1926, AMEX from 1962, and NASDAQ from 1972; CRSP Indexes; NASDAQ and S&P 500 Composite Indices
Organon (OGN) delivered earnings and revenue surprises of 7.76% and 5.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?